Close Menu

NEW YORK (GenomeWeb) – BioMérieux said today that its first quarter revenues rose 4 percent year over year, driven by a moderate flu season and strong sales momentum in the Asia-Pacific region.

For the three months ended March 31, the company reported revenues of €632.5 million ($707.8 million), up from €587 million in the prior-year period. At constant exchange rates and scope of consolidation, revenues grew 8 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.